Commonwealth Numbered Regulations

[Index] [Table] [Search] [Search this Regulation] [Notes] [Noteup] [Previous] [Next] [Download] [Help]

NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) AMENDMENT REGULATIONS 2010 (NO.5) (SLI NO 296 OF 2010) - REG 9

Transitional -- listed brand moving from first or second transitional disclosure cycle to main disclosure cycle

         (1)   This regulation applies if:

                 (a)     regulation 6 applies to a listed brand of a pharmaceutical item; and

                (b)     the brand is in the first transitional disclosure cycle or the second transitional disclosure cycle.

         (2)   The brand moves to a main disclosure cycle on 1 October 2011.

         (3)   The data collection period for the brand in the main disclosure cycle:

                (a)    begins on 1 October 2011; and

               (b)    ends at the end of 30 September 2012.


AustLII: Copyright Policy | Disclaimers | Privacy Policy | Feedback